1331 related articles for article (PubMed ID: 19524458)
1. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease pilot study.
Oto A; Fan X; Mustafi D; Jansen SA; Karczmar GS; Rubin DT; Kayhan A
Acad Radiol; 2009 Oct; 16(10):1223-30. PubMed ID: 19524458
[TBL] [Abstract][Full Text] [Related]
2. Measurement of MRI enhancement kinetics for evaluation of inflammatory activity in Crohn's disease.
Röttgen R; Grandke T; Grieser C; Lehmkuhl L; Hamm B; Lüdemann L
Clin Imaging; 2010; 34(1):29-35. PubMed ID: 20122516
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
4. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
Bisdas S; Baghi M; Wagenblast J; Bisdas T; Thng CH; Mack MG; Koh TS; Ernemann U
Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200
[TBL] [Abstract][Full Text] [Related]
5. Role of spectral presaturation attenuated inversion-recovery fat-suppressed T2-weighted MR imaging in active inflammatory bowel disease.
Udayasankar UK; Martin D; Lauenstein T; Rutherford R; Galloway J; Tudorascu D; Sitaraman SV
J Magn Reson Imaging; 2008 Nov; 28(5):1133-40. PubMed ID: 18972354
[TBL] [Abstract][Full Text] [Related]
6. [Quantifying the inflammatory activity in Crohn's disease using CE dynamic MRI].
Pauls S; Kratzer W; Rieber A; Schmidt SA; Mittrach C; Adler G; Brambs HJ; Gabelmann A
Rofo; 2003 Aug; 175(8):1093-9. PubMed ID: 12886478
[TBL] [Abstract][Full Text] [Related]
7. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging of the small bowel in Crohn's disease.
Frøkjaer JB; Larsen E; Steffensen E; Nielsen AH; Drewes AM
Scand J Gastroenterol; 2005 Jul; 40(7):832-42. PubMed ID: 16109660
[TBL] [Abstract][Full Text] [Related]
9. Limitations of single slice dynamic contrast enhanced MR in pharmacokinetic modeling of bone sarcomas.
Toms AP; White LM; Kandel R; Bleakney RR; Noseworthy M; Lee S; Blackstein ME; Wunder J
Acta Radiol; 2009 Jun; 50(5):512-20. PubMed ID: 19431058
[TBL] [Abstract][Full Text] [Related]
10. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
[TBL] [Abstract][Full Text] [Related]
11. A method for pharmacokinetic modelling of dynamic contrast enhanced MRI studies of rapidly enhancing lesions acquired in a clinical setting.
Radjenovic A; Ridgway JP; Smith MA
Phys Med Biol; 2006 May; 51(9):N187-97. PubMed ID: 16625029
[TBL] [Abstract][Full Text] [Related]
12. Scan-rescan variability in perfusion assessment of tumors in MRI using both model and data-derived arterial input functions.
Ashton E; Raunig D; Ng C; Kelcz F; McShane T; Evelhoch J
J Magn Reson Imaging; 2008 Sep; 28(3):791-6. PubMed ID: 18777526
[TBL] [Abstract][Full Text] [Related]
13. MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn's disease of the terminal ileum.
Girometti R; Zuiani C; Toso F; Brondani G; Sorrentino D; Avellini C; Bazzocchi M
Acad Radiol; 2008 Feb; 15(2):153-64. PubMed ID: 18206614
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic evaluation of chronic inflammatory intestinal diseases in children and adolescents: MRI with true-FISP as new gold standard?].
Hohl C; Haage P; Krombach GA; Schmidt T; Ahaus M; Günther RW; Staatz G
Rofo; 2005 Jun; 177(6):856-63. PubMed ID: 15902636
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis.
Walker-Samuel S; Leach MO; Collins DJ
Phys Med Biol; 2006 Jul; 51(14):3593-602. PubMed ID: 16825751
[TBL] [Abstract][Full Text] [Related]
16. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization.
Kim JK; Hong SS; Choi YJ; Park SH; Ahn H; Kim CS; Cho KS
J Magn Reson Imaging; 2005 Nov; 22(5):639-46. PubMed ID: 16200542
[TBL] [Abstract][Full Text] [Related]
17. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
[TBL] [Abstract][Full Text] [Related]
18. Mapping of T1-values and Gadolinium-concentrations in MRI as indicator of disease activity in luminal Crohn's disease: a feasibility study.
Horsthuis K; Nederveen AJ; de Feiter MW; Lavini C; Stokkers PC; Stoker J
J Magn Reson Imaging; 2009 Feb; 29(2):488-93. PubMed ID: 19161209
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
Ocak I; Bernardo M; Metzger G; Barrett T; Pinto P; Albert PS; Choyke PL
AJR Am J Roentgenol; 2007 Oct; 189(4):849. PubMed ID: 17885055
[TBL] [Abstract][Full Text] [Related]
20. Evidence for shutter-speed variation in CR bolus-tracking studies of human pathology.
Yankeelov TE; Rooney WD; Huang W; Dyke JP; Li X; Tudorica A; Lee JH; Koutcher JA; Springer CS
NMR Biomed; 2005 May; 18(3):173-85. PubMed ID: 15578708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
